Danaher Q3 Revenues Dip Slightly, Lowers 2012 EPS Guidance
October 18, 2012
Danaher Q3 Revenues Dip Slightly, Lowers 2012 EPS Guidance
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Danaher's Q1 Revenues up 31 Percent, Aided by Beckman Coulter Purchase
April 19, 2012 / GenomeWeb Daily News - Danaher Q3 Revenues Increase 46 Percent
October 20, 2011 / GenomeWeb Daily News - Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News - Cancer Genetics Reports 45 Percent Increase in Q1 Revenues, Maps out Growth Strategy
May 16, 2013 / GenomeWeb Daily News - RXi Q1 Loss Rises on Opko Deal Charge
May 16, 2013 / Gene Silencing News